Update shared on 30 Nov 2025
Fair value Decreased 1.99%Analysts have revised AMERISAFE's price target downward, with the consensus fair value decreasing by about $1 to $49.33. They cite ongoing valuation pressures and a stable but modest financial outlook for the insurance sector.
Analyst Commentary
Analysts covering AMERISAFE have recently provided updated perspectives on the stock, reflecting both optimism and caution regarding the company’s outlook amid ongoing industry headwinds.
Bullish Takeaways- Bullish analysts anticipate that AMERISAFE’s exposure to lighter-than-usual catastrophe losses will support more stable earnings in the coming quarters.
- Stable profitability continues to underpin confidence in the company’s ability to weather broader property and casualty sector volatility.
- Potential mark to market gains in book value are highlighted as near-term catalysts that could boost shareholder value.
- Some analysts view the current pricing environment as an opportunity for disciplined execution, supporting their view of an outperform rating for the stock.
- Bearish analysts emphasize ongoing valuation pressures across the industry, viewing AMERISAFE’s shares as fairly valued with limited upside.
- There is caution regarding persistent issues around casualty loss reserves, which could weigh on sector-wide sentiment and the company’s risk profile.
- Expectations for only modest growth in profitability suggest limited room for near-term upside, contributing to more neutral ratings.
- The price target reductions signal concerns over constrained financial performance and a lack of significant earnings acceleration.
What's in the News
- Truist reduced its price target for AMERISAFE shares from $50 to $45. The firm maintained a Hold rating due to valuation pressures in the property and casualty industry (Truist research note).
- Chief Financial Officer Anastasios Omiridis announced his intent to resign, effective November 30, 2025. The company has launched a search for a new CFO (company announcement).
- AMERISAFE declared a special cash dividend of $1.00 per share, payable on December 12, 2025, to shareholders of record as of December 5, 2025 (company announcement).
- The company completed additional share buybacks, including 2,765 shares for $0.12 million under the July 2025 tranche. In total, AMERISAFE has repurchased 1,773,703 shares for $46.01 million since March 2010 (company filings).
Valuation Changes
- Consensus Analyst Price Target has decreased by approximately $1 to $49.33, reflecting a downward adjustment in fair value estimates.
- Discount Rate remains virtually unchanged at 6.96%, suggesting stable assumptions about risk and return expectations.
- Revenue Growth projections have dropped slightly from 4.61% to 4.50%, signaling a more conservative outlook for future top-line expansion.
- Net Profit Margin has decreased modestly from 9.94% to 9.59%, indicating expectations of slightly lower profitability.
- Future P/E ratio has increased from 31.44x to 32.04x, suggesting the stock is now valued at a slightly higher multiple of forward earnings.
Have other thoughts on AMERISAFE?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
